Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Mul…

Moxifloxacin, a fourth generation fluoroquinolone, which has good antibacterial activity against both Gram-positive cocci and Gram-negative bacteria. To date, there are no meta-analysis to evaluate the efficacy and safety of moxifloxacin for multidrug resistant tuberculosis (MDR-TB) treatment. This meta-analysis to explore the efficacy and safety of the moxifloxacin in treatment of MDR-TB in ad…

Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment o…

Moxifloxacin is a recommended drug for rifampin-resistant tuberculosis (RR-TB) treatment, but there is limited pediatric pharmacokinetic and safety data, especially in young children. We characterize moxifloxacin population pharmacokinetics and QT interval prolongation and evaluate optimal dosing in children with RR-TB

Tuberkulosis paru: pedoman penataan diagnostik dan terapi

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

616.995 TUB

Tuberkulosis paru: masalah dan penanggulannya

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

616.995 ADI t

Tuberkulosis klinis, ed. 2

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

616.995 CRO t

Tuberkulosis : diagnosis, terapi dan masalahnya, ed. 4

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

616.995 ADI t